Adams Wealth Management Boosts Stock Position in Humana Inc. (NYSE:HUM)

Adams Wealth Management raised its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 24.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,717 shares of the insurance provider's stock after acquiring an additional 1,899 shares during the period. Adams Wealth Management's holdings in Humana were worth $2,465,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the stock. FPC Investment Advisory Inc. purchased a new position in Humana in the fourth quarter worth approximately $27,000. Centricity Wealth Management LLC acquired a new stake in shares of Humana in the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA lifted its position in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management purchased a new stake in shares of Humana during the 4th quarter worth $33,000. Finally, Atwood & Palmer Inc. grew its stake in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Performance

Shares of NYSE:HUM traded down $21.20 during midday trading on Friday, hitting $264.41. The stock had a trading volume of 3,670,273 shares, compared to its average volume of 1,759,722. The company has a market capitalization of $31.91 billion, a PE ratio of 26.57, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The stock has a 50 day moving average price of $265.90 and a two-hundred day moving average price of $270.03. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's payout ratio is currently 35.58%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on HUM shares. JPMorgan Chase & Co. decreased their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Morgan Stanley decreased their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Truist Financial increased their price target on shares of Humana from $290.00 to $325.00 and gave the company a "hold" rating in a research note on Friday, April 11th. Royal Bank of Canada restated an "outperform" rating and issued a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Finally, Mizuho lifted their price target on shares of Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $284.90.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.